OptimizeRx Corporation
OPRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20,110 | -$17,566 | -$11,438 | $378 |
| Dep. & Amort. | $4,329 | $2,402 | $2,022 | $1,965 |
| Deferred Tax | $1,449 | $0 | $0 | $0 |
| Stock-Based Comp. | $11,466 | $13,717 | $15,746 | $5,492 |
| Change in WC | $921 | -$15,550 | $3,961 | -$7,189 |
| Other Non-Cash | $6,834 | $9,757 | $364 | $80 |
| Operating Cash Flow | $4,889 | -$7,240 | $10,654 | $726 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$112 | -$87 | -$81 | -$100 |
| Net Acquisitions | $0 | -$80,407 | -$2,000 | $0 |
| Inv. Purchases | $0 | -$162,778 | -$55,932 | $0 |
| Inv. Sales/Matur. | $0 | $218,709 | $0 | $0 |
| Other Inv. Act. | -$338 | -$774 | -$164 | -$386 |
| Investing Cash Flow | -$450 | -$25,337 | -$58,176 | -$486 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$4,000 | $36,020 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $70,672 |
| Stock Repurch. | -$911 | -$7,522 | -$20,024 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$278 | $1,073 | $3,253 |
| Financing Cash Flow | -$4,911 | $28,220 | -$18,951 | $73,925 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$472 | -$4,357 | -$66,473 | $74,165 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $13,852 | $18,209 | $84,682 | $10,517 |
| End Cash | $13,380 | $13,852 | $18,209 | $84,682 |
| Free Cash Flow | $4,777 | -$8,111 | $10,410 | $240 |